Numerous strategies may be needed to control IFIS

Article

Intraoperative floppy iris syndrome (IFIS) can be approached in a number of ways depending on the surgical scenario, according to David Chang, MD, University of California, San Francisco.

Intraoperative floppy iris syndrome (IFIS) can be approached in a number of ways depending on the surgical scenario,according to David Chang, MD, University of California, San Francisco.

"There is great variability in how the iris responds among patients with IFIS," Dr. Chang said. "We have to control it, or itmay or may not work, which is why multiple strategies are needed."

The first approach that he uses, an ophthalmic viscosurgical device (OVD), provides good pupillary dilation in patients whoare taking tamsulosin (Flomax, Boehringer Ingelheim Pharmaceuticals), as Dr. Chang demonstrated in a mild case of IFIS.Gentle hydrodissection, horizontal chopping, and low flow are advised in these cases, he said. The key to using an OVD is toprolong its duration in the eye. He achieves visco mydriasis by refilling the eye with a proprietary OVD, 2.3% sodiumhyaluronate (Healon5, Advanced Medical Optics), as needed. However, he noted, there is a learning curve associated with theuse of this OVD.

Another strategy in patients with IFIS in whom an OVD alone may not work is the use of intracameral epinephrine, whichprovides pupillary rigidity and eliminates any billowing of the iris. In these cases, epinephrine is mixed with balanced saltsolution in a 1:4 ratio. Dr. Chang demonstrated a case in which epinephrine was used, there was no prolapse, and the irisbillowing stopped. In cases of severe IFIS, epinephrine may need more time to work.

When epinephrine is ineffective, Dr. Chang reported that he combines 2.3% sodium hyaluronate and epinephrine to dilate thepupil successfully.

In patients with a small pupil, iris retractors (available from Katena and FCI) may be used when intracameral epinephrine isineffective. Dr. Chang makes a separate stab incision from the phaco incision. The retractor forms the iris in a diamondconfiguration, which eliminates tenting of the iris and provides good exposure nasally for chopping.

The latest strategy is the disposable expansion ring. This device provides a 6-mm pupil diameter. The ring has a low profileallowing for easy access of the instrument to the eye. Dr. Chang said that, in his opinion, he considers one proprietary ring(Malyugin Ring, Microsurgical Technologies) to be among the easiest devices to use.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.